🔎 Trials Near Me

Utama › Penyakit Crohn › Missouri › St. Louis

Kajian klinikal Penyakit Crohn di St. Louis, MO

19 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi dalam dan sekitar St. Louis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Mengambil pesertaFasa 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Mengambil pesertaFasa 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Mengambil pesertaFasa 3
  • Washington University School of Medicine ( Site 5058), St Louis
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Mengambil pesertaFasa 4
  • SSM Health Medical Group, Bridgeton · 15 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Mengambil pesertaFasa 2
  • Washington University /ID# 266938, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Mengambil pesertaFasa 3
  • Washington University School of Medicine, St Louis
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Mengambil pesertaFasa 3
  • Washington University School of Medicine, St Louis
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Mengambil pesertaFasa 2
  • KAD Clinical Research, St Louis
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi jauh
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Mengambil pesertaFasa 2
  • KAD Clinical Research, St Louis
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Mengambil pesertaFasa 4
  • Washington University School of Medicine, St Louis
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

Mengambil pesertaFasa 2
  • Washington University, St. Louis, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Mengambil pesertaFasa 2
  • Washington University School of Medicine, St Louis
Umur 18 hingga 80 · Semua jantina · Dikemas kini 5 Jun 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Mengambil pesertaFasa 2
  • Investigational Site Number: 8400013, St Louis
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mengambil pesertaFasa 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

Mengambil pesertaFasa 1/2
  • Washington University in St. Louis, St Louis
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Mengambil pesertaKajian pemerhatian
  • Washington University in St Louis School of Medicine, St Louis
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT06670638

Kajian Penyakit Crohn di bandar lain

Kajian lain di St. Louis

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.